Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- CheckyesterdayChange DetectedThe Record History now includes a new revision entry, v3.7.0, replacing the previous revision v3.6.6. This change represents an update to the page's version history rather than modifications to trial data or content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.6.6 was added and the previous v3.6.5 entry removed, indicating a platform update to the page's history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.5 was added to the page’s history and the previous revision v3.6.4 was removed from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedA new site revision entry, Revision: v3.6.4, was added to the record history and the previous Revision: v3.6.3 entry was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedNo textual changes are listed for this study record.SummaryDifference0.1%

- Check79 days agoChange DetectedThe Record History now shows a new revision entry, v3.6.3, replacing the previous v3.6.2. This reflects a minor site update to the study's record history rather than a change to trial details.SummaryDifference0.1%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.